NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study - Berzigotti, A; Bellot, P; De Gottardi, A (Am J Gastroenterol, 2010)
et al.